Rui Avelar's Net Worth
$6.63 Million
Who is Rui Avelar?
Rui Avelar has an estimated net worth of $6.63 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., and ANGIOTECH PHARMACEUTICALS INC.
SEC CIK
Rui Avelar's CIK is 0001432063
Past Insider Trading and Trends
2024 was Rui Avelar's most active year for acquiring shares with 4 total transactions. Rui Avelar's most active month to acquire stocks was the month of December. 2024 was Rui Avelar's most active year for disposing of shares, totalling 3 transactions. Rui Avelar's most active month to dispose stocks was the month of February. 2019 saw Rui Avelar paying a total of $99,999.60 for 70,020 shares, this is the most they've acquired in one year. In 2020 Rui Avelar cashed out on 39,442 shares for a total of $422,281.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evolus, Inc. (EOLS) Snapshot price: $14.71
See RemarksRui Avelar owns 368,847 units of Common Stock which is worth $5,425,739.37. From 2018 to 2024 Rui Avelar acquired a total of 385,231 shares in Evolus, Inc. at a cost of $99,999.60, Rui also disposed a total of 116,608 shares of Evolus, Inc. equalling to $1,302,201.76.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.92% | -3.44K |
$12.72 | -$43,760.57 | 368.85K |
May 10
| |||
Form 4
| -6.90% | -27.60K |
$13.92 | -$384,349.69 | 372.29K |
Mar 19
| |||
Form 4
| +2.91% | 11.29K |
$13.08 | -$23,820.87 | 399.89K |
Scheduled
|
Feb 21 - Feb 22
| ||
Form 4
| +9.96% | 35.21K |
—
|
—
| 388.6K |
Feb 7
| |||
Form 4
| +5.20% | 17.46K |
$10.27 | -$22,706.97 | 353.39K |
Aug 14 - Aug 16
| |||
Form 4
| -4.25% | -14.91K |
$8.47 | -$126,237.42 | 335.93K |
Scheduled
|
Mar 14
| ||
Form 4
| +38.56% | 97.64K |
—
|
—
| 350.83K |
Jan 25
| |||
Form 4
| -3.87% | -10.19K |
$9.73 | -$99,121.28 | 253.19K |
Scheduled
|
Mar 8
| ||
Form 4
| +25.53% | 53.57K |
—
|
—
| 263.38K |
Jan 24
| |||
Form 4
| -6.38% | -14.29K |
$11.18 | -$159,788.59 | 209.81K |
Scheduled
|
Aug 10
| ||
Form 4
| +67.11% | 90K |
—
|
—
| 224.1K |
Jan 27
| |||
Form 4
| -1.97% | -2.70K |
$7.46 | -$20,134.54 | 134.1K |
Scheduled
|
Jan 25
| ||
Form 4
| +41.32% | 40K |
—
|
—
| 136.8K |
May 13
| |||
Form 4
| +36.72% | 26K |
—
|
—
| 96.8K |
Jan 23
| |||
Form 4
| -35.78% | -39.44K |
$10.71 | -$422,281.83 | 70.8K |
Scheduled
|
Jan 7
| ||
Form 4
| +10.00% | 10.02K |
$9.98 | $99,999.60 | 110.24K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANGIOTECH PHARMACEUTICALS INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||